Quick Facts
Biography
Mark Fishman is a noted researcher and clinician in cardiology and the previous President of the Novartis Institutes for BioMedical Research (NIBR), the main research arm of Novartis Pharmaceuticals with over 6,700 employees and a 2012 budget of more than $9B.
Fishman was appointed President of the newly founded Novartis Institutes for BioMedical Research in 2002 to implement a new strategy in Novartis' global drug discovery effort. He is the author of over 100 publications and known for pioneering research using the zebrafish as a means of visualizing the development of the circulatory system and as a model for human disease.
Education
- B.A. Yale College, 1972
- M.D. Harvard Medical School, 1976
Career
He was previously a Professor of Medicine at Harvard Medical School, Chief of Cardiology at Massachusetts General Hospital, and director of the Cardiovascular Research Center at Massachusetts General Hospital. He is a fellow of the National Academy of Arts and Sciences and a member of the National Academy of Sciences, Institute of Medicine.
After being the head of Novartis for 13 years, he has decided to retire in 2016.